Edwards Lifesciences Corporation Financials

Market Capitalization $40.65 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	26.61
Forward PE	28.13
Price to Sales TTM	$6.44
Price to Book MRQ	$4.26
Enterprise to Revenue	5.86
Enterprise to EBITDA	18.02

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	65.86%
Operating Margin	29.11%
Return on Assets TTM	10.65%
Return on Equity TTM	19.14%

Income Statement

Revenue TTM	$6,314,899,968
Revenue per Share TTM	$10.50
Quarterly Revenue Growth	8.90%
Gross Profit TTM	$4,837,199,872
EBITDA	$1,792,100,000
Net Income to Common TTM	$1,567,299,968
Diluted EPS TTM	$2.59
Quarterly Earnings Growth YoY	697.80%

Balance Sheet

Total Cash MRQ	$4,446,099,968
Total Cash per Share MRQ	$7.54
Total Debt MRQ	$
Total Debt to Equity MRQ	7.35
Current Ratio MRQ	3.46
Book Value per Share MRQ	$16.18

Cash Flow

Operating Cash Flow TTM	$806,400,000
Levered Free Cash Flow TTM	$1,792,337,536

EW Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	589,800,000
Float Shares	583,778,142
Avg 10 Volume	4,582,080
Avg 30 Volume	None
Shares Short	11,310,531
Short Ratio	2.10
Short % of Shares	1.93%
% Held by Insiders	0.91%
% Held by Institutions	86.72%

Stock Price Summary

Beta	1.12
Fifty Two Week Low	$58.93
Fifty Two Week High	$96.12
Fifty Two Week Change	-8.09%
Day 50 MA	$71.62
Day 200 MA	$76.22

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date	2020-06-01